ArticleJournal of immunoassay & immunochemistry2010

Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients.

Andrea L Small-Howard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.